Cargando…
Tumor parameters predict the risk of side effects after ruthenium-106 plaque brachytherapy of uveal melanomas
BACKGROUND: To report on radiation-related side effects and complications after ruthenium-106 plaque brachytherapy of uveal melanomas. METHODS: Medical records of 143 eyes with uveal melanoma, treated by ruthenium-106 brachytherapy between 1997 and 2012 at a single center, were analyzed. We evaluate...
Autores principales: | Tarmann, Lisa, Wackernagel, Werner, Ivastinovic, Domagoj, Schneider, Mona, Winkler, Peter, Langmann, Gerald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578662/ https://www.ncbi.nlm.nih.gov/pubmed/28859118 http://dx.doi.org/10.1371/journal.pone.0183833 |
Ejemplares similares
-
Brachytherapy of Uveal Melanomas with Ruthenium-106 Plaques
por: Belaïd, Asma, et al.
Publicado: (2016) -
(106)Ruthenium eye plaque brachytherapy in the management of medium sized uveal melanoma
por: Jiang, Ping, et al.
Publicado: (2020) -
Nomogram for predicting radiation maculopathy in patients treated with Ruthenium-106 plaque brachytherapy for uveal melanoma
por: Tagliaferri, Luca, et al.
Publicado: (2017) -
Long-Term Outcomes in Uveal Melanoma After Ruthenium-106 Brachytherapy
por: Cennamo, Gilda, et al.
Publicado: (2022) -
Efficacy and complications of ruthenium-106 brachytherapy for uveal melanoma: a systematic review and meta-analysis
por: Karimi, Saeed, et al.
Publicado: (2021)